BDNF and hydrops fetalis: In patients with systolic HF, lower circulating BDNF levels are independently associated with more severe structural cardiac changes, worse echocardiographic parameters, higher N-terminal pro B-type Natriuretic Peptide (NT-proBNP) levels, and worse clinical outcomes, supporting its utility as a biomarker of disease severity [47,48].